Global Medical Cannabis Market, by Pain Management, by Type, 2018-2027

Growth Outlook

• The 2027 portion of the Global Medical Cannabis Market, by Pain Management, by Type, 2018 market is on a steady long-term growth path. Segment value stands at roughly USD 7150 Mn in 2026 and is projected to reach USD 8226 Mn by 2027 — a gain of about 15% over the forecast period, translating to a CAGR in the double digits.
• The use of medical cannabis has garnered significant attention globally in recent years due to its potential for pain management and improving quality of life for patients with various medical conditions. Medical cannabis, also known as medical marijuana, is the use of the cannabis plant or its basic components to alleviate symptoms of certain medical conditions or to treat specific diseases.
• What the regional split looks like (2026): Cancer leads, holding roughly 49% of segment value — the single largest regional share. Inflammatory Pain is the second-largest contributor. Neuropathic Pain make up the remainder, in descending order.
• By 2027, Cancer alone is expected to reach USD 4084 Mn, with Inflammatory Pain at USD 2098 Mn.

Market Dynamics

The use of medical cannabis has garnered significant attention globally in recent years due to its potential for pain management and improving quality of life for patients with various medical conditions. Medical cannabis, also known as medical marijuana, is the use of the cannabis plant or its basic components to alleviate symptoms of certain medical conditions or to treat specific diseases. It contains numerous chemicals called cannabinoids that have shown to have therapeutic benefits. One of the primary uses of medical cannabis is pain management. Chronic pain affects millions of people worldwide and can have a significant impact on daily life. Studies have shown that cannabinoids in cannabis can effectively treat chronic pain. The cannabinoids work by interacting with the body's endocannabinoid system, which plays a crucial role in regulating pain. This interaction can reduce inflammation, which is often the cause of chronic pain, and provide relief to patients. Additionally, medical cannabis has been found to be beneficial in managing pain associated with various medical conditions such as cancer, multiple sclerosis, and arthritis. It has also been shown to help improve sleep quality and reduce anxiety and depression, which are often associated with chronic pain.

The demand for medical cannabis in pain management is further driven by its relatively safe profile compared to traditional pain medications. Opioids, for example, are known to be highly addictive and can cause severe adverse effects. In contrast, medical cannabis has a lower risk of addiction and fewer side effects, making it a more attractive option for patients. Furthermore, the increasing legalization and decriminalization of medical cannabis in various countries have also contributed to the growth of the global market. As more countries recognize the medical benefits of cannabis, the demand for it is expected to continue to rise. When it comes to types of medical cannabis, the demand is increasing for both natural and synthetic forms. Natural cannabis, in the form of dried flower or oil extracts, is the most commonly used. However, there is a growing demand for synthetic cannabinoids, which are produced in a laboratory. Synthetic cannabinoids offer a more precise dosage and consistency, making them a preferred choice for medical professionals. In conclusion, the demand for medical cannabis in pain management is on the rise globally, and it is expected to continue to grow in the future.

The therapeutic benefits and relatively safe profile of medical cannabis make it a promising option for patients and healthcare professionals alike. With the increasing legalization of medical cannabis in countries worldwide and the availability of different types, the global medical cannabis market is set to witness significant growth in the coming years.

Research Methodology

Figures reflect Wantstats’ original market research and forecasting models, compiled as part of the Wantstats research archive and published in 2024.